Option Care Health (NASDAQ:OPCH) Lowered to Hold Rating by Wall Street Zen

Wall Street Zen cut shares of Option Care Health (NASDAQ:OPCH) from a buy rating to a hold rating in a report published on Saturday.

Other research analysts also recently issued reports about the stock. Cowen assumed coverage on shares of Option Care Health in a research report on Thursday, October 2nd. They set a “hold” rating on the stock. TD Cowen decreased their target price on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating for the company in a research note on Monday, November 3rd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Option Care Health in a research note on Thursday. Morgan Stanley initiated coverage on Option Care Health in a report on Friday, October 17th. They set an “overweight” rating and a $35.00 price objective for the company. Finally, Citigroup restated an “outperform” rating on shares of Option Care Health in a research note on Friday, October 31st. Nine investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and an average target price of $35.67.

Option Care Health Trading Down 1.5%

NASDAQ:OPCH opened at $28.41 on Friday. The stock has a market cap of $4.51 billion, a PE ratio of 22.73, a price-to-earnings-growth ratio of 1.74 and a beta of 0.88. Option Care Health has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The stock’s 50-day moving average is $27.77 and its two-hundred day moving average is $29.60.

Insider Buying and Selling at Option Care Health

In related news, Director Norman L. Wright acquired 3,411 shares of the stock in a transaction dated Tuesday, September 9th. The shares were acquired at an average price of $29.31 per share, with a total value of $99,976.41. Following the acquisition, the director owned 15,501 shares in the company, valued at approximately $454,334.31. The trade was a 28.21% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of Option Care Health stock in a transaction that occurred on Monday, November 3rd. The stock was bought at an average price of $25.98 per share, with a total value of $987,240.00. Following the completion of the acquisition, the director owned 413,390 shares in the company, valued at approximately $10,739,872.20. The trade was a 10.12% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased a total of 97,411 shares of company stock worth $2,614,816 over the last three months. Corporate insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in OPCH. Schonfeld Strategic Advisors LLC acquired a new stake in shares of Option Care Health in the third quarter worth $2,998,000. Creative Planning raised its holdings in Option Care Health by 1.5% in the 3rd quarter. Creative Planning now owns 105,876 shares of the company’s stock worth $2,939,000 after acquiring an additional 1,575 shares during the period. Lazard Asset Management LLC lifted its position in Option Care Health by 15.2% during the 3rd quarter. Lazard Asset Management LLC now owns 16,174 shares of the company’s stock worth $449,000 after acquiring an additional 2,135 shares during the last quarter. Zacks Investment Management boosted its holdings in Option Care Health by 8.9% during the third quarter. Zacks Investment Management now owns 65,819 shares of the company’s stock valued at $1,827,000 after acquiring an additional 5,400 shares during the period. Finally, Virtu Financial LLC boosted its holdings in Option Care Health by 37.2% during the third quarter. Virtu Financial LLC now owns 12,795 shares of the company’s stock valued at $355,000 after acquiring an additional 3,470 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.